Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Aug 7, 2015 · 10-Q · 38 days after period end · 0001193125-15-282886
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$23.11M | -$19.01M | -$15.41M | -$4.57M |
| EPS Diluted | -$0.74 | -$0.78 | -$1.01 | -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 7, 2015 · 38 d after period end
